Breaking News
August 21, 2018 - Clinical Trials Balance Out Urban, Rural Cancer Survival Rates
August 21, 2018 - New target found for treating thoracic aortic aneurysm
August 21, 2018 - Tumor cells’ ‘tells’ may allow some cancer patients to dodge unnecessary chemotherapy
August 21, 2018 - Dehydration changes shape and activity of the brain, reduces task performance
August 21, 2018 - Scientists discover peptides that can be used as new antibiotic candidates
August 21, 2018 - ‘Compulsivity circuit’ may drive alcohol-seeking behavior in heavy drinkers
August 21, 2018 - Type 2 diabetes on the rise among youngsters
August 21, 2018 - Genital warts may promote HIV sexual transmission
August 21, 2018 - Drop the C-word to reduce anxiety and overtreatment, say experts
August 21, 2018 - Kid-friendly MRI equipment has advantages for grown-ups, too
August 21, 2018 - Scleroderma Foundation names Tulane professor as ‘Doctor of the Year’
August 21, 2018 - Chagas disease causes chronic heart disease and has spread outside of Latin America
August 21, 2018 - FDA stirs debate by approving ‘natural’ app
August 21, 2018 - Clay may help fight disease-causing bacteria in wounds
August 21, 2018 - Emerging field of diabetology could address growing crisis in health care
August 21, 2018 - Experts examine stool protein biomarkers that indicate inflammatory bowel disease
August 21, 2018 - Orphazyme Announces Enrollment of First Patient in Phase III Clinical Trial of Arimoclomol for ALS
August 21, 2018 - Ovarian cancer cells hoard iron to fuel growth
August 21, 2018 - New Biodesign fellows will focus on vision care
August 21, 2018 - Prenatal DDT Exposure Associated with Greater Risk of Autism
August 21, 2018 - Cruciferous vegetables found to protect against colon cancer in mice
August 21, 2018 - New studies point to a promising future for bioengineered teeth
August 21, 2018 - ACR expresses concerns on step therapy in a recent meeting with HSS Secretary
August 21, 2018 - Gene therapy with telomerase does not increase cancer risk, study shows
August 21, 2018 - Ovarian cancer screening influenced by unconscious bias, study shows
August 21, 2018 - Scientists report novel gene therapy that halts vision loss in canine model of blinding disease
August 21, 2018 - RxBenefits introduces new tailored and flexible approach to managing hospital pharmacy benefits
August 21, 2018 - Motif Bio Announces FDA Acceptance of New Drug Application With Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
August 21, 2018 - Google Glass helps kids with autism read facial expressions, study finds
August 21, 2018 - Thrombospondin-1 contributes to development of aortic aneurysm in mice and humans, study finds
August 21, 2018 - National Foundation for Cancer Research receives Safeway Foundation grant
August 21, 2018 - Protein aggregation in neurons linked to gene regulation in Huntington’s disease
August 21, 2018 - Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA
August 21, 2018 - FDA Approves Opdivo (nivolumab) for Certain Patients with Previously Treated Small Cell Lung Cancer
August 21, 2018 - Success of blood test for autism affirmed
August 21, 2018 - Diabetic patients with disrupted sleep may need more time to heal their wounds
August 21, 2018 - AADE honors six educators for achievements in diabetes education
August 21, 2018 - Scientists find two molecules that may combat cancer and chronic infections
August 21, 2018 - Two Strategies for Preventing Diabetes in Minority Patients
August 21, 2018 - Living as a Gallbladder Cancer Survivor
August 21, 2018 - Can we predict the long-term outcome of boys with ADHD?
August 21, 2018 - GBCA creates model for developing scientist-advocate collaborations in cancer research
August 21, 2018 - Healthy diet could help promote healthy cellular aging in women
August 21, 2018 - Researchers develop gene expression predictor for immunotherapy response in melanoma
August 21, 2018 - Genome sequences of ape parasites provide insights on origin and early evolution of malaria
August 21, 2018 - MDI Biological Laboratory introduces Morris Scientific Discovery Fund for eligible research programs
August 21, 2018 - Pediatric brain tumor patients who undergo radiation less likely to recall recently experienced events
August 21, 2018 - Micro-flow model reveals complex interactions between the brain’s blood vessels and nerve cells
August 21, 2018 - Study investigates impact of osteoporosis on risk of developing dementia
August 21, 2018 - Federal method fails to detect most stores that sell cigarettes to minors
August 21, 2018 - Workers in open office seating have less stress than those in private offices and cubicles
August 21, 2018 - 1 in 4 in U.S. Has a Disability, CDC Reports
August 21, 2018 - Studies provide new insights into the role of sleep in chronic pain
August 21, 2018 - Study shows that rogue proteins may underlie some ALS and frontotemporal dementia cases
August 21, 2018 - Elevated LDL cholesterol levels linked to higher risk of CVD death in young, healthy people
August 21, 2018 - Measles cases on the rise in Europe
August 21, 2018 - CURE Media Group welcomes CancerCare to Strategic Alliance Partnership Program
August 21, 2018 - Blood management program associated with fewer transfusions in orthopedic patients
August 21, 2018 - Researchers create the world’s first artificial retina
August 21, 2018 - Yale researchers identify racial disparities in prescribing opioids for chronic pain
August 21, 2018 - BOOST-3 clinical trial aims to improve outcomes for severe TBI patients
August 21, 2018 - New study highlights Alzheimer’s herpes link, experts say
August 21, 2018 - Airline crew don’t have significantly elevated risk of thyroid cancer, new study finds
August 21, 2018 - States leverage federal funds to help insurers lower premiums
August 21, 2018 - New badge course explores research around skeletal muscle as an endocrine organ
August 21, 2018 - TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis
August 21, 2018 - Increased levels of human herpesvirus ID’d in Alzheimer’s
August 21, 2018 - To help patients quash pain, researcher develops practical guide for health care providers
August 20, 2018 - Medicine on the front line to be presented at Medical Innovation 2018
August 20, 2018 - Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody
August 20, 2018 - The man who sold America on vitamin D — and profited in the process
August 20, 2018 - Finding the light in antimicrobials
August 20, 2018 - Unique pain program helps surgical patients wean off opioids safely and effectively
August 20, 2018 - Strawberries could mitigate colonic inflammation
August 20, 2018 - FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters
August 20, 2018 - Using Facebook to help young adults quit smoking
August 20, 2018 - ‘Liquid biopsy’ predicts lymphoma therapy success within days | News Center
August 20, 2018 - 5 Questions with Jordan Orange, Chair of Pediatrics
August 20, 2018 - New assay may help improve both sarcoma diagnosis and treatment
August 20, 2018 - New information on the brain regions related to metacognition, tactile sense
Stem cells remain healthy following low-dose X-ray exposure, say biophysicists

Stem cells remain healthy following low-dose X-ray exposure, say biophysicists

image_pdfDownload PDFimage_print

Biophysicists have shown that following low-dose exposure to X-rays (at 80 milligrays), stem cells remain healthy, proliferate, and do not accumulate DNA damage to be passed on to their progeny. The paper was published in the journal Aging.

“The 80-milligray dose is equivalent to the radiation exposure during a medical diagnostic imaging procedure such as a CT scan, which is routinely used in conjunction with stem cell therapy,” explains Sergey Leonov, director of the Phystech School of Biological and Medical Physics at MIPT, who also heads the institute’s Laboratory for the Development of Innovative Drugs. “Our research helps predict the side effects and health risks for patients, who are increasingly often undergoing both stem cell therapy and diagnostic X-ray procedures at the same time.”

The field of regenerative medicine, which is now making rapid advances, holds the promise of using stem cells to replace or restore damaged human tissues and organs. Stem cells have a high potential for division and self-renewal, and are capable of differentiating into various cell types. They are present in most organs and tissues in an adult organism and can identify damage sites, migrate toward them, replace damaged cells, and promote healing. However, stem cells are believed to be harmed by frequent medical diagnostic procedures involving the use of ionizing radiation, such as CT scans and mammography. According to this view, X-rays cause damage that is accumulated in stem cells and passed on to their progeny. This supposedly leads to cell death, accelerated cellular aging, and malignant transformations.

The international research team, including Andreyan Osipov from Burnasyan Federal Medical Biophysical Center and MIPT’s Sergey Leonov and Anastasia Tsvetkova, ran a series of experiments aimed at obtaining the much needed data on the delayed effects of low-dose radiation exposure. They showed that low-dose X-ray exposure does not induce genome instability, premature aging, or the accumulation of DNA damage in the progeny of irradiated cells.

Cellular response to X-ray irradiation

During a regular X-ray exam, a dose of about 0.001-10 milligrays — depending on the procedure — is delivered to the patient. Receiving 100 mGy is considered low-dose exposure, while 1,000 mGy is regarded as an intermediate dose. The effects of larger-dose exposure have been studied extensively. It is known to cause a dose-dependent increase in the incidence of DNA lesions, including the so-called double-strand breaks in which both strands of the double helix are severed. These breaks can lead to cell death, oncogene activation, and anti-oncogene inactivation.

In contrast, the effects of low-dose radiation exposure during routine X-ray exams are still poorly understood. The regulatory agencies responsible for radiation protection currently use the so-called linear no-threshold model to estimate radiation risks. Under this model, ionizing radiation is harmful to living cells, no matter how low the dose. However, this crude assumption does not reflect the actual state of affairs: We are regularly exposed to natural background radiation, and its absence even has adverse effects on the ability of cells to repair DNA damage.

Criteria for assessing the effects of low-dose exposure

Among the various types of DNA lesions caused by ionizing radiation, double-strand breaks get most of the attention of researchers, because their long-term effects on cells are the most pronounced. Their repair takes long, and uncorrected double-strand breaks lead to serious cytogenetic abnormalities, tumor suppressor gene inactivation, oncogene activation, and cell death.

For a long time, no method was available for evaluating the generation of DNA double-strand breaks due to low-dose radiation exposure. The classical methods could only describe the effects of large-dose exposure. Now, advances in immunocytochemistry, have given biophysicists the tools needed to quantify double-strand breaks caused by low-dose X-ray exposure and look into how they are distributed in the nucleus and repaired by the cell.

As proteins involved in the correction of DNA damage accumulate at the site of a double-strand break, they can be observed with a microscope thanks to immunofluorescence staining — a technique that involves treating antibodies with fluorescent dyes. This enables scientists to visualize DNA lesions as bright dots called foci. One of the proteins widely used as a DNA damage marker is the histone variant called γH2AX.

Effects on progeny cells

The cell has two main mechanisms for repairing double-strand breaks. The first one, called homologous recombination, is a slow but virtually error-free way of restoring the lost information in a damaged DNA sequence. The other one, nonhomologous end joining, may lead to a loss of genetic information, resulting in errors and mutations. And yet it is this faster but inaccurate mechanism that is used to repair eight out of 10 breaks occurring in an irradiated cell.

The researchers found that 24 hours after low-dose X-ray treatment, more γH2AX foci are observed in stem cells, compared to those exposed to an intermediate dose of radiation. However, this was only true for cells undergoing division and not for quiescent cells (see fig. 2). DNA double-strand breaks are known to occur naturally during cell division. Such breaks are usually mended correctly via homologous recombination. When the progeny of the cells were examined 11 passages, or “cellular generations,” after the exposure to low-dose radiation, the researchers found them to be no different from the progeny of the control cells, which were not treated with X-rays. Furthermore, the progeny of the cells that received low-dose irradiation did not exhibit genome instability, proliferation abnormalities, or accelerated senescence (see figs. 2 and 3).

Andreyan Osipov, professor of the Russian Academy of Sciences and the head of the Experimental Radiobiology and Radiation Medicine Department at Federal Medical Biophysical Center, comments on the team’s findings: “Our research suggests that the presence of γH2AX foci in cultured human stem cells 24 hours after low-dose X-ray irradiation is associated with cell division processes and does not lead to delayed effects related to aging. This is an important conclusion to draw, because γH2AX foci are now actively used in biodosimetry. Misunderstanding the biological significance of residual foci might lead to a severe overestimation of the risks associated with low-dose exposure.”

Source:

https://mipt.ru/english/news/low_dose_x_ray_exposure_does_not_harm_human_stem_cells

Tagged with:

About author

Related Articles